Zyceva 150mg: A Powerful Treatment Option for Non-Small Cell Lung Cancer

Zyceva 150mg Tablet contains erlotinib (150mg), a targeted therapy designed to treat certain types of non-small cell lung cancer. This medication works by inhibiting the activity of tyrosine kinase receptors, disrupting the growth and spread of cancer cells within the body.

How it Works: Erlotinib is specifically targeted towards epidermal growth factor receptor (EGFR) mutations present in certain cancers. By blocking these mutated receptors, Zyceva interferes with tumor cell signaling pathways, leading to reduced tumor growth and progression.

Key Features:

* Efficacy: Zyceva has been shown to be effective in reducing the size of tumors in patients with advanced non-small cell lung cancer.
* Safety: While generally well-tolerated, side effects may occur and vary among individuals. These can include diarrhea, nausea, and vomiting. Medical supervision and monitoring are crucial during treatment.

Important Note: This medication is a prescription-only drug. Consult your healthcare professional for appropriate diagnosis and dosage recommendations before use.